Familial Hypercholesterolemia: The Discordance Between Its Prevalence and Diagnostic Rate
Although familial hypercholesterolemia (FH) is not an extremely rare disease, many clinicians think it is not common. If we will try to find out FH, it would be frequently met in real clinical practice. Our first speaker, Prof. Raul D. Santos from University of Sao Paulo, Brazil, will discuss the issues associated with the cardiovascular risk heterogeneity and try to show how to identify the severe forms of FH. Our second speaker, Prof. Sang-Hyun Kim from Seoul National University, South Korea, will talk about the recent findings and future perspectives in pharmacotherapy treating FH. Our third speaker, Prof. Brian Tomlinson from Macau University of Science & Technology, Macau, will talk about the discordance of FH care. Our last speaker, Prof. Sang-Hak Lee from Yonsei University, South Korea, will present the interesting findings about the response to lipid lowering therapy according to the genetic background in FH.